- Home
- MSM vs DNLI Comparison
MSM vs DNLI Comparison
Compare MSM & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- DNLI
- Stock Information
- Founded
- MSM 1941
- DNLI 2013
- Country
- MSM United States
- DNLI United States
- Employees
- MSM N/A
- DNLI N/A
- Industry
- MSM Industrial Machinery/Components
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSM Industrials
- DNLI Health Care
- Exchange
- MSM Nasdaq
- DNLI Nasdaq
- Market Cap
- MSM 5.0B
- DNLI 4.5B
- IPO Year
- MSM 1995
- DNLI 2017
- Fundamental
- Price
- MSM $83.03
- DNLI $25.05
- Analyst Decision
- MSM Hold
- DNLI Strong Buy
- Analyst Count
- MSM 5
- DNLI 11
- Target Price
- MSM $87.25
- DNLI $38.90
- AVG Volume (30 Days)
- MSM 821.4K
- DNLI 788.0K
- Earning Date
- MSM 01-07-2025
- DNLI 11-06-2024
- Dividend Yield
- MSM 4.09%
- DNLI N/A
- EPS Growth
- MSM N/A
- DNLI N/A
- EPS
- MSM 4.58
- DNLI N/A
- Revenue
- MSM $3,820,951,000.00
- DNLI N/A
- Revenue This Year
- MSM N/A
- DNLI N/A
- Revenue Next Year
- MSM $4.68
- DNLI $283.75
- P/E Ratio
- MSM $18.14
- DNLI N/A
- Revenue Growth
- MSM N/A
- DNLI 204.74
- 52 Week Low
- MSM $75.05
- DNLI $14.56
- 52 Week High
- MSM $104.76
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- MSM 47.02
- DNLI 37.93
- Support Level
- MSM $87.77
- DNLI $26.17
- Resistance Level
- MSM $90.81
- DNLI $33.33
- Average True Range (ATR)
- MSM 2.07
- DNLI 1.64
- MACD
- MSM 0.17
- DNLI -0.13
- Stochastic Oscillator
- MSM 34.18
- DNLI 0.66
About MSM MSC Industrial Direct Company Inc.
MSC Industrial Direct is one of the largest industrial distributors with a focus on metalworking and maintenance, repair, and operations products and services. The company offers over 2 million products through its distribution network, which has 11 fulfillment centers. Although MSC has a presence in Canada, Mexico, and the United Kingdom, it primarily operates in the United States. In fiscal 2023, 95% of the firm's $4.0 billion of sales was generated in the US.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.